Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

Scientists employ deep learning to analyze and compare gene regulation across various cell types in human and chicken brains.

Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.

Muhle is one of many supporters of Legislative Bill 338 from State Sen. Dave “Woody” Wordekemper of Fremont, which seeks to ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

The last year (and particularly the last few months) of the Biden Administration brought a flurry of activity from the Federal Trade Commission ...

Blood proteins serve as crucial indicators of health and disease risk throughout development. Now, researchers at the ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Scientists have identified a tiny genetic change—present in nearly all living humans but absent in our closest extinct ...